Prospective and multicenter studies are needed to confirm whether uKIM-1 and YKL-40 can act as prognostic markers toward the progression of albuminuria in T2DM patients with increased levels, independent of their albuminuria status. The gene discussed is CHI3L1; the disease is type 2 diabetes mellitus.